| scholarly article | Q13442814 |
| P356 | DOI | 10.1038/CR.2008.69 |
| P2888 | exact match | https://scigraph.springernature.com/pub.10.1038/cr.2008.69 |
| P698 | PubMed publication ID | 18560380 |
| P5875 | ResearchGate publication ID | 5295110 |
| P2093 | author name string | Li Zhao | |
| Tao Yin | |||
| Kang Cheng | |||
| Haichang Wang | |||
| Xinliang Ma | |||
| P2860 | cites work | Isolation of putative progenitor endothelial cells for angiogenesis | Q28302884 |
| Angiotensin II stimulates intercellular adhesion molecule-1 (ICAM-1) expression by human vascular endothelial cells and increases soluble ICAM-1 release in vivo | Q28374109 | ||
| Mechanisms of angiogenesis and arteriogenesis | Q29617257 | ||
| Transplanted cord blood-derived endothelial precursor cells augment postnatal neovascularization | Q30876047 | ||
| Aldosterone enhances ischemia-induced neovascularization through angiotensin II-dependent pathway. | Q33201419 | ||
| Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization | Q33870103 | ||
| Endothelial progenitor cells: new hope for a broken heart | Q35160551 | ||
| Endothelial progenitor cells: characterization and role in vascular biology | Q35867837 | ||
| Angiotensin II regulation of ovine fetoplacental artery endothelial functions: interactions with nitric oxide | Q36080082 | ||
| Circulating endothelial progenitor cells, vascular function, and cardiovascular risk | Q39513285 | ||
| Origin of endothelial progenitors in human postnatal bone marrow | Q39737487 | ||
| Evidence for the importance of angiotensin II type 1 receptor in ischemia-induced angiogenesis | Q39737596 | ||
| Bone marrow-derived progenitor cells modulate vascular reendothelialization and neointimal formation: effect of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibition | Q40697868 | ||
| C-reactive protein attenuates endothelial progenitor cell survival, differentiation, and function: further evidence of a mechanistic link between C-reactive protein and cardiovascular disease. | Q42460041 | ||
| Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease | Q43664648 | ||
| Statin therapy accelerates reendothelialization: a novel effect involving mobilization and incorporation of bone marrow-derived endothelial progenitor cells | Q44039853 | ||
| Estrogen increases bone marrow-derived endothelial progenitor cell production and diminishes neointima formation | Q44480707 | ||
| Phosphatidylinositol 3-kinase/Akt regulates angiotensin II-induced inhibition of apoptosis in microvascular endothelial cells by governing survivin expression and suppression of caspase-3 activity | Q44764233 | ||
| Angiotensin II potentiates vascular endothelial growth factor-induced proliferation and network formation of endothelial progenitor cells | Q44789396 | ||
| Antagonism of the renin-angiotensin system can counteract cardiac angiogenic vascular endothelial growth factor gene therapy and myocardial angiogenesis in the normal heart | Q45887364 | ||
| Suppression of endothelial progenitor cells in human coronary artery disease by the endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine | Q46780282 | ||
| Role of renin angiotensin system in angiogenesis: it is still elusive | Q47835231 | ||
| Angiotensin II type 1a receptor is involved in cell infiltration, cytokine production, and neovascularization in infarcted myocardium. | Q51037313 | ||
| Origin of endothelial progenitors in human postnatal bone marrow | Q56778012 | ||
| Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells | Q58816342 | ||
| Stromal cell-derived factor-1 effects on ex vivo expanded endothelial progenitor cell recruitment for ischemic neovascularization | Q73106062 | ||
| Nitric oxide induces angiogenesis and upregulates alpha(v)beta(3) integrin expression on endothelial cells | Q73190805 | ||
| Physical training increases endothelial progenitor cells, inhibits neointima formation, and enhances angiogenesis | Q75201497 | ||
| Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization | Q77323614 | ||
| Improvement of collateral perfusion and regional function by implantation of peripheral blood mononuclear cells into ischemic hibernating myocardium | Q78500111 | ||
| Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures | Q78570627 | ||
| Bone marrow molecular alterations after myocardial infarction: Impact on endothelial progenitor cells | Q82562427 | ||
| P433 | issue | 7 | |
| P304 | page(s) | 792-799 | |
| P577 | publication date | 2008-07-01 | |
| P1433 | published in | Cell Research | Q1524018 |
| P1476 | title | Angiotensin II promotes NO production, inhibits apoptosis and enhances adhesion potential of bone marrow-derived endothelial progenitor cells | |
| P478 | volume | 18 |
| Q91386840 | Activation of heme oxygenase-1 by Ginkgo biloba extract differentially modulates endothelial and smooth muscle-like progenitor cells for vascular repair |
| Q37859447 | Angiotensin II and the vascular phenotype in hypertension |
| Q26748814 | Angiotensin II type 1 receptor antagonists in animal models of vascular, cardiac, metabolic and renal disease |
| Q46944330 | Angiotensin II-derived reactive oxygen species promote angiogenesis in human late endothelial progenitor cells through heme oxygenase-1 via ERK1/2 and AKT/PI3K pathways |
| Q86194511 | Apolipoprotein A-I mimetic peptide reverse D-4F improves the biological functions of mouse bone marrow-derived late EPCs via PI3K/AKT/eNOS pathway |
| Q49385822 | Association of circulating progenitor cells with angiotensin II in newly diagnosed hypertensive patients. |
| Q26765959 | Bone marrow-derived cells in ocular neovascularization: contribution and mechanisms |
| Q53038373 | CCN1 enhances angiogenic potency of bone marrow transplantation in a rat model of hindlimb ischemia. |
| Q51652823 | Combined iNO and endothelial progenitor cells improve lung alveolar and vascular structure in neonatal rats exposed to prolonged hyperoxia. |
| Q35069503 | Endothelial progenitor cell biology in disease and tissue regeneration |
| Q40032796 | Enhanced endothelial progenitor cell angiogenic potency, present in early experimental renovascular hypertension, deteriorates with disease duration |
| Q36019557 | Enhanced penetration of exogenous EPCs into brains of APP/PS1 transgenic mice |
| Q37921158 | LOX-1 and angiotensin receptors, and their interplay |
| Q35563549 | NO to breast: when, why and why not? |
| Q34784406 | Neuregulin-1β regulation of embryonic endothelial progenitor cell survival |
| Q45969435 | Nitric oxide as an initiator of brain lesions during the development of Alzheimer disease. |
| Q37887771 | Nitric oxide: a guardian for vascular grafts? |
| Q38086269 | Normal and abnormal pulmonary arteriovenous shunting: occurrence and mechanisms |
| Q33649852 | Novel role of NADPH oxidase in angiogenesis and stem/progenitor cell function. |
| Q37245483 | Obstructive sleep apnea and endothelial progenitor cells |
| Q37039329 | Pinocembrin, a major flavonoid in propolis, improves the biological functions of EPCs derived from rat bone marrow through the PI3K-eNOS-NO signaling pathway |
| Q33776274 | Rapamycin inhibits re-endothelialization after percutaneous coronary intervention by impeding the proliferation and migration of endothelial cells and inducing apoptosis of endothelial progenitor cells |
| Q33587136 | Role of the renin angiotensin system on bone marrow-derived stem cell function and its impact on skeletal muscle angiogenesis |
| Q46486488 | The ROS derived mitochondrial respirstion not from NADPH oxidase plays key role in Celastrol against angiotensin II-mediated HepG2 cell proliferation |
| Q34836751 | The characteristics of endothelial progenitor cells derived from mononuclear cells of rat bone marrow in different culture conditions |
| Q38006725 | The renin-angiotensin system, bone marrow and progenitor cells |
| Q84587894 | Toll-like receptor 4 signaling in dysfunction of cardiac microvascular endothelial cells under hypoxia/reoxygenation |
| Q37570669 | Transplantation of endothelial progenitor cells as therapeutics for cardiovascular diseases |
| Q37345998 | Vascular endothelial growth factor-A signaling in bone marrow-derived endothelial progenitor cells exposed to hypoxic stress |
| Q35207893 | Vascular inflammation and endothelial dysfunction in experimental hypertension. |
Search more.